Infectious Disease
News on research and diagnostic development for pathogenic diseases.
The firm filed for Chapter 11 protection on Thursday and is seeking to sell its assets after facing turmoil in recent years.
Accelerate Diagnostics Files for Chapter 11 Bankruptcy Protection
The company has received a commitment of up to $12.5 million in a multi-draw DIP financing facility to provide funding during the proceeding.
OraSure's Q1 Core Revenues Down 2 Percent
The firm brought in revenues of $29.9 million in Q1, down 45 percent from $54.1 million in Q1 2024 but narrowly beating the consensus Wall Street estimate of $29.6 million.
QuidelOrtho Q1 Revenues Slide 3 Percent
The firm's non-respiratory revenues slid a fraction of 1 percent year over year, while its respiratory revenues were down 13 percent.
Diasorin Q1 Revenues Rise 8 Percent
The firm reported growth across its immunodiagnostics and molecular diagnostics businesses as well as contributions from the firm's licensed technologies business.